Therapeutics and Speciality Expertise
Meta-Works has assisted enterprises launch, manage and promote their therapeutics and services across many disease states in a wide array of markets. It has developed a reputation for rapid familiarisation of new products and the intricacies associated with new and existing markets.
Please see below for details on Evident’s breadth of drug experience in strategic therapeutic areas.
Oncology
Health Technology Assessments on monoclonal antibodies, aromatase inhibitors, vinea alkaloids, other chemotherapies erythropoiesis stimulating agents, immune-suppressants, steroidal aromatase inactivators in the cancer focus areas of:
HIV/AIDS
Systematic and Marketing reviews in the focus area of HIV on various antiretroviral medication including nucleoside reverse transcriptase inhibitors, protease inhibitors.
Cardiovascular
Feasibility assessment on new product registrations and extensions on:
blood pressure lowering drugs
heart failure and ventricula impairment
Dermatology
Reimbursement applications in actinic keratosis, solar keratosis & rosacea as:
Immune response modifiers
Sensitizers used in photodynamic/radiation therapy -ingenol mebutate
Obstetrics & Gynaecology
Regulatory & pricing applications in the focus areas of:
Contraceptive drugs & devices
Psychiatry
Regulatory submissions, systematic reviews and reimbursement submissions on:
tetracyclic antidepressants
SSNRIs
Erectile Dysfunction
Health Technology Assessments and market reviews on:
prostaglandin
tadalafil
Rare Diseases
Global review of manufacturers’ incentives. Ultra/Orphan drug applications and regulatory submissionsin:
Inflammation
Systematic reviews in rheumatoid arthritis, Crohn’s disease, osteoarthritis, adrenocortical deficiency states of:
TNF inhibitors
adalimumab
COX-2 selective NSAIDs
chimeric monoclonal antibody
glucocorticoid
Anti-Parasitics
Literature-based submissions on macrocyclic lactone medicines in parasite infestations of:
Typical scabies
Crusted scabies
Wound Care
Reimbursement submissions on
medicated band aides
biosynthetic meshes
Coagulation Disorders
Orphan applications, literature- based submissions on recombinants, low molecular weight heparin, warfarin, rivaroxaban, dabigitran, edoxaban, apixaban, tranexamic acid in the focus areas of:
Glanzmann’s thrombasthenia
Factor VII deficiency
Pain Management
Regulatory and Pricing applications for:
oxycodone
fentanyl
buprenorphine
ibuprofen
paracetamol